111, Inc. ('111' or the 'Company') is a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services in China. The Company provides consumers with better access to pharmaceutical products and healthcare services directly through its online retail pharmacy, 1 Pharmacy, and indirectly through its offline virtual pharmacy network. The Company also offers online healthcare services through its internet hospital, 1 Clinic, which provides consumers with cost-effective and convenient online consultation, electronic prescription service, and patient management service. In addition, the Company's online wholesale pharmacy, 1 Medicine Marketplace, serves as a one-stop shop for pharmacies to source a vast selection of pharmaceutical products. With the largest virtual pharmacy network in China, 111 enables offline pharmacies to better serve their customers with cloud-based services. 111 also provides an omni-channel drug commercialization platform to its strategic partners, which includes services such as digital marketing, patient education, data analytics, and pricing monitoring.
Company profile
Ticker
YI
Exchange
Website
CEO
Jun Ling Liu
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
SEC CIK
YI stock data
Latest filings (excl ownership)
6-K
111, Inc. Announces Third Quarter 2022 Unaudited Financial Results
1 Dec 22
6-K
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
23 Sep 22
6-K
111 Inc. Receives Unsolicited Preliminary Non-Binding Proposal to Acquire the Company
9 Sep 22
6-K
111, Inc. Announces Second Quarter 2022 Unaudited Financial Results
25 Aug 22
6-K
111, Inc. Announces First Quarter 2022 Unaudited Financial Results
16 Jun 22
6-K
111, Inc. Provides Updates on its Status Under the Holding Foreign Companies Accountable Act
5 May 22
20-F
2021 FY
Annual report (foreign)
29 Apr 22
6-K
111, Inc. Announces Fourth Quarter and Fiscal Year 2021 Financial Results
17 Mar 22
6-K
Current report (foreign)
1 Mar 22
6-K
111, Inc. Announces Third Quarter 2021 Unaudited Financial Results
19 Nov 21
Transcripts
YI
Earnings call transcript
2022 Q3
1 Dec 22
YI
Earnings call transcript
2022 Q2
25 Aug 22
YI
Earnings call transcript
2022 Q1
16 Jun 22
YI
Earnings call transcript
2021 Q4
17 Mar 22
YI
Earnings call transcript
2021 Q3
19 Nov 21
YI
Earnings call transcript
2021 Q2
27 Aug 21
YI
Earnings call transcript
2021 Q1
19 May 21
YI
Earnings call transcript
2020 Q4
18 Mar 21
YI
Earnings call transcript
2020 Q3
19 Nov 20
Latest ownership filings
SC 13D/A
Gang Yu
31 Oct 22
SC 13D
Gang Yu
9 Sep 22
SC 13G/A
ClearVue Partners, L.P.
10 Feb 22
SC 13G/A
Verlinvest Asia (HK) Ltd
27 May 21
SC 13G/A
ClearVue Partners, L.P.
5 Feb 21
SC 13G/A
111, Inc.
24 Feb 20
SC 13G/A
111, Inc.
29 Jan 20
SC 13G
111, Inc.
14 Feb 19
SC 13G
111, Inc.
11 Feb 19
SC 13G
111, Inc.
28 Jan 19
Financial summary
| Quarter (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
Institutional ownership, Q3 2022
| 13F holders | Current |
|---|---|
| Total holders | 18 |
| Opened positions | 5 |
| Closed positions | 5 |
| Increased positions | 2 |
| Reduced positions | 6 |
| 13F shares | Current |
|---|---|
| Total value | 208.86 mm |
| Total shares | 65.19 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Gang Yu | 36.00 mm | $0.00 |
| ClearVue Partners | 18.35 mm | $64.22 mm |
| Verlinvest Asia | 7.62 mm | $136.00 mm |
| Greenwoods Asset Management Hong Kong | 836.44 k | $2.24 mm |
| JPM JPMorgan Chase & Co. | 735.89 k | $1.97 mm |
| Artal | 686.43 k | $1.84 mm |
| BCS Barclays | 329.80 k | $884.00 k |
| Marshall Wace | 201.80 k | $539.00 k |
| Renaissance Technologies | 111.35 k | $298.00 k |
| Prelude Capital Management | 108.40 k | $291.00 k |
News
Charter Communications, Braze And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
14 Dec 22
Why Vallon Pharmaceuticals Shares Are Trading Higher By Over 150%; Here Are 29 Stocks Moving Premarket
14 Dec 22
10 Consumer Staples Stocks Moving In Tuesday's Pre-Market Session
13 Dec 22
Reuters Reported Earlier China's 111.inc App Starts Retail Sales of Pfizer's Paxlovid for COVID
13 Dec 22
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
12 Dec 22